| Applicant Company |
Astrazeneca Pharmaceuticals (Phils.), Inc.
|
| Brand Name |
Imfinzi 120 Mg/2.4 Ml (50 Mg/Ml) Concentrate For Solution For Iv Infusion
|
| Generic Name |
Durvalumab
|
| Dosage Strength |
120 mg/2.4 mL (50 mg/mL)
|
| Dosage Form |
Concentrate For Solution For Iv Infusion
|
| Packaging |
2.4 mL net content Type I glass vial with chlorobutyl rubber stopper and a dark gray flip-off aluminum seal
|
| Pharmacologic Category |
Monoclonal Antibodies
|
| Application Type |
Monitored Release
|